C
Constantinos O'Mahony
Researcher at St Bartholomew's Hospital
Publications - 55
Citations - 3050
Constantinos O'Mahony is an academic researcher from St Bartholomew's Hospital. The author has contributed to research in topics: Hypertrophic cardiomyopathy & Sudden cardiac death. The author has an hindex of 24, co-authored 51 publications receiving 2320 citations. Previous affiliations of Constantinos O'Mahony include University College London Hospitals NHS Foundation Trust & Barts Health NHS Trust.
Papers
More filters
Journal ArticleDOI
A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)
Constantinos O'Mahony,Fatima Jichi,Menelaos Pavlou,Lorenzo Monserrat,Aristides Anastasakis,Claudio Rapezzi,Elena Biagini,Juan R. Gimeno,Giuseppe Limongelli,William J. McKenna,Rumana Z Omar,Perry M. Elliott +11 more
TL;DR: This is the first validated SCD risk prediction model for patients with HCM and provides accurate individualized estimates for the probability of SCD using readily collected clinical parameters.
Journal ArticleDOI
Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review
Oliver P Guttmann,M. Shafiqur Rahman,Constantinos O'Mahony,Aris Anastasakis,Perry M. Elliott +4 more
TL;DR: LA dimension and age are independently associated with AF but the literature is insufficient to create robust clinical tools to predict AF or thromboembolism; most data suggest that AF patients should be anticoagulated.
Journal ArticleDOI
The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy
Constantinos O'Mahony,Pier D. Lambiase,Giovanni Quarta,Montserrat Cardona,Margherita Calcagnino,Konstantinos Tsovolas,Shereen Al-Shaikh,Shafiqur M. Rahman,Samer Arnous,Sue Jones,William J. McKenna,Perry M. Elliott +11 more
TL;DR: HCM patients with an ICD have a significant cardiovascular mortality and are exposed to frequent inappropriate shocks and implant complications, which suggest that new strategies are required to improve patient selection for ICDs and to prevent disease progression in those that receive a device.
Journal ArticleDOI
Prevalence of desmosomal protein gene mutations in patients with dilated cardiomyopathy.
Perry M. Elliott,Constantinos O'Mahony,Petros Syrris,Alison Evans,Christina Rivera Sorensen,Mary N. Sheppard,Gerald Carr-White,Antonios Pantazis,William J. McKenna +8 more
TL;DR: This study suggests that both clinical presentations of heart failure caused by a dilated, poorly contracting left ventricle and arrhythmogenic right ventricular cardiomyopathy can be caused by mutations in desmosomal protein genes.
Journal ArticleDOI
A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy
Constantinos O'Mahony,Maite Tome-Esteban,Pier D. Lambiase,Antonios Pantazis,S Dickie,William J. McKenna,Perry M. Elliott +6 more
TL;DR: The power of the 2003 ACC/ESC and 2011 ACCF/AHA SCD risk stratification algorithms to distinguish high risk patients who might be eligible for an implantable cardioverter defibrillator (ICD) from low risk individuals with limited power is assessed.